Silo Pharma, Inc. (SILO) stock
SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.71+0.14 (+8.57%)
Close on Nov 17, 2026Market cap $2.72MP/E –Yield –
Silo Pharma cash
Cash and short-term investments held at the end of each period.
Silo Pharma's cash was $5.23M at Jun 30, 2026. For fiscal 2025 it was $6.86M, down 3.1% from the year before. Over ten years it grew 13.1% a year on average. The highest annual figure on record is $11.37M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.86M | -3.1% |
| FY2024 | Dec 31, 2024 | $7.08M | -7.6% |
| FY2023 | Dec 31, 2023 | $7.67M | -32.6% |
| FY2022 | Dec 31, 2022 | $11.37M | +15.6% |
| FY2021 | Dec 31, 2021 | $9.84M | +771.8% |
| FY2020 | Dec 31, 2020 | $1.13M | +909.7% |
| FY2019 | Dec 31, 2019 | $111.75K | -66.8% |
| FY2018 | Dec 31, 2018 | $336.68K | +14.3% |
| FY2017 | Dec 31, 2017 | $294.59K | -49.1% |
| FY2016 | Dec 31, 2016 | $579.21K | -71.2% |
| FY2013 | Dec 31, 2013 | $2.01M | +720552.3% |
| FY2012 | Dec 31, 2012 | $279 | -84.1% |
| FY2011 | Dec 31, 2011 | $1.75K | -96.3% |
| FY2010 | Dec 31, 2010 | $47.48K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.23M | -16.5% |
| Q1 FY2026 | Mar 31, 2026 | $6.03M | +10.7% |
| Q4 FY2025 | Dec 31, 2025 | $6.86M | -3.1% |
| Q3 FY2025 | Sep 30, 2025 | $5.87M | -26.8% |
| Q2 FY2025 | Jun 30, 2025 | $6.26M | -17.7% |
| Q1 FY2025 | Mar 31, 2025 | $5.45M | -28.9% |
| Q4 FY2024 | Dec 31, 2024 | $7.08M | -19.3% |
| Q3 FY2024 | Sep 30, 2024 | $8.02M | -19.8% |
| Q2 FY2024 | Jun 30, 2024 | $7.61M | -33.1% |
| Q4 FY2023 | Dec 31, 2023 | $7.67M | -37.4% |
| Q3 FY2023 | Sep 30, 2023 | $8.77M | +0.4% |
| Q1 FY2023 | Jun 30, 2023 | $9.99M | +10.1% |
| Q4 FY2022 | Dec 31, 2022 | $11.37M | +15.6% |
| Q3 FY2022 | Sep 30, 2022 | $12.25M | +19.4% |
| Q2 FY2022 | Jun 30, 2022 | $8.73M | +110.4% |
| Q1 FY2022 | Mar 31, 2022 | $9.07M | +95.6% |
| Q4 FY2021 | Dec 31, 2021 | $9.84M | +771.8% |
| Q3 FY2021 | Sep 30, 2021 | $10.26M | +523.5% |
| Q2 FY2021 | Jun 30, 2021 | $4.15M | +116.3% |
| Q1 FY2021 | Mar 31, 2021 | $4.64M | +50611.4% |
| Q4 FY2020 | Dec 31, 2020 | $1.13M | +909.7% |
| Q3 FY2020 | Sep 30, 2020 | $1.65M | +6601.9% |
| Q2 FY2020 | Jun 30, 2020 | $1.92M | +2393.6% |
| Q1 FY2020 | Mar 31, 2020 | $9.14K | -94.8% |
| Q4 FY2019 | Dec 31, 2019 | $111.75K | -66.8% |
| Q3 FY2019 | Sep 30, 2019 | $24.56K | -96.1% |
| Q2 FY2019 | Jun 30, 2019 | $76.97K | -90.1% |
| Q1 FY2019 | Mar 31, 2019 | $177.35K | -63.5% |
| Q4 FY2018 | Dec 31, 2018 | $336.68K | +14.3% |
| Q3 FY2018 | Sep 30, 2018 | $626.12K | +107.5% |
| Q2 FY2018 | Jun 30, 2018 | $776.21K | +34.0% |
| Q1 FY2018 | Mar 31, 2018 | $486.27K | -75.8% |
| Q4 FY2017 | Dec 31, 2017 | $294.59K | -20.1% |
| Q3 FY2017 | Sep 30, 2017 | $301.69K | +2888.2% |
| Q4 FY2016 | Dec 31, 2016 | $579.21K | +207501.8% |
| Q4 FY2013 | Dec 31, 2013 | $2.01M | +720552.3% |
| Q2 FY2013 | Jun 30, 2013 | $368.68K | – |
| Q1 FY2013 | Mar 31, 2013 | $10.10K | – |
| Q4 FY2012 | Dec 31, 2012 | $279 | – |
| Q3 FY2012 | Sep 30, 2012 | $279 | – |
See a number that looks wrong?